<DOC>
	<DOCNO>NCT01400867</DOCNO>
	<brief_summary>This study safety , effectiveness , blood level tolerance Ceftaroline fosamil child skin infection receive antibiotic therapy hospital .</brief_summary>
	<brief_title>Safety Efficacy Study Ceftaroline Versus Comparator Pediatric Subjects With Complicated Skin Infections</brief_title>
	<detailed_description>To evaluate safety , effectiveness , pharmacokinetics tolerance Ceftaroline fosamil child initially hospitalize Acute Bacterial Skin Skin Structure Infections ( ABSSSI ) .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Cephalexin</mesh_term>
	<mesh_term>Aztreonam</mesh_term>
	<criteria>Male female , 2 month &lt; 18 year old . Presence ABSSSI warrant initial hospitalization . Presence ABSSSI measurable margin erythema , include deep and/or extensive soft tissue involvement , require significant therapeutic surgical intervention Documented history hypersensitivity allergic reaction vancomycin , aztreonam , βlactam antimicrobial Uncomplicated skin soft tissue infection More 24 hour prior antimicrobial therapy ≤ 96 hour randomization . Requirement concomitant systemic antimicrobial therapy History seizure , exclude welldocumented febrile seizure childhood . Clinical sign suspicion meningitis</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Infections</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Teflaro</keyword>
	<keyword>cephalosporin</keyword>
</DOC>